John Maher.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 35522096.
- Also identified by DOI 10.1016/j.xcrm.2022.100595 and PMC identifier 9460943.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
John Maher has worked on CAR T cell immunotherapy with a primary focus on solid tumors for over 20 years. In this Q&A, Cell Reports Medicine interviewed him about his journey in this arena and next steps.
Medical subject headings
- Immunotherapy, Adoptive
- Neoplasms